ÂÜÀòÂÒÂ×

Dr. Birner joined TVM Capital in 2000, and is a General Partner for life sciences in the firm’s Munich office. He currently serves as Chairman of the Board of Argos Therapeutics Inc. (Durham, North Carolina) and is a member of the Board of Directors of Evotec AG (Hamburg, Germany), BioXell SA (Milan, Italy), Spepharm Holding BV (Amsterdam, Netherlands), Proteon Therapeutics, Inc (Kansas City, Missouri), Transmolecular Inc.(Boston, Massachusetts) and Nitec Pharma SA (Basel, Switzerland). Over many years, he was the Chairman/Vice Chairman of Direvo Biotech AG (Cologne, Germany) and Jerini AG (Berlin, Germany) which were acquired in 2008 by Bayer HealthCare AG and Shire Ltd. Dr. Birner also represents the interests of TVM Capital with Ardana Bioscience plc (Edinburgh, Scotland).